Operating Cash Flow per Share: A measure of financial performance calculated as operating cash flow, expressed on a per share basis. Calculated as: Cash Flow from Operations / Weighted Average Shares Outstanding (Diluted)
Integrated BioPharma Inc. (INBP) had Operating Cash Flow per Share of $0.04 for the most recently reported fiscal year, ending 2026-06-30.
| Income Statement Financials | |
$43.87M |
|
$-2.84M |
|
$43.07M |
|
$0.80M |
|
$46.58M |
|
$-2.71M |
|
$0.14M |
|
$-2.56M |
|
$-2.56M |
|
$-2.84M |
|
$-2.84M |
|
$-2.84M |
|
$-2.84M |
|
$-2.71M |
|
$-1.32M |
|
31.06M |
|
31.06M |
|
$-0.09 |
|
$-0.09 |
|
| Balance Sheet Financials | |
$17.38M |
|
$1.75M |
|
$7.96M |
|
$25.34M |
|
$5.80M |
|
$0.07M |
|
$1.87M |
|
$7.67M |
|
$17.67M |
|
$17.67M |
|
$17.67M |
|
31.09M |
|
| Cash Flow Statement Financials | |
$1.24M |
|
$-0.34M |
|
$-0.04M |
|
$3.62M |
|
$4.47M |
|
$0.86M |
|
$0.19M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.00 |
|
-- |
|
-- |
|
0.00 |
|
0.01 |
|
1.82% |
|
-6.17% |
|
-6.17% |
|
-3.00% |
|
-5.84% |
|
-6.48% |
|
$0.90M |
|
-- |
|
-- |
|
-- |
|
1.73 |
|
4.71 |
|
13.16 |
|
27.74 |
|
-16.09% |
|
-16.09% |
|
-11.22% |
|
-16.03% |
|
$0.57 |
|
$0.03 |
|
|
Operating Cash Flow per Share |
$0.04 |